Global Immuno-oncology Therapy Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Immuno-oncology Therapy market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Immuno-oncology Therapy market are covered in Chapter 9:
Spectrum Pharmaceuticals
Amgen
BioNTech SE
Pfizer
Rubius Therapeutics
Novartis
Gritstone Oncology
IMAB-I-Mab Biopharma Co., Ltd.
Janssen Biotech
Autolus Therapeutics
Allogene Therapeutics
Bristol-Myers Squibb
Merck
Eli-Lilly
Takeda
GlaxoSmithKline
Arcus Biosciences
Roche
AstraZeneca
Sanofi
In Chapter 5 and Chapter 7.3, based on types, the Immuno-oncology Therapy market from 2017 to 2027 is primarily split into:
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
In Chapter 6 and Chapter 7.4, based on applications, the Immuno-oncology Therapy market from 2017 to 2027 covers:
Hospitals
Ambulatory Surgical Center
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Immuno-oncology Therapy market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Immuno-oncology Therapy Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Immuno-oncology Therapy market are covered in Chapter 9:
Spectrum Pharmaceuticals
Amgen
BioNTech SE
Pfizer
Rubius Therapeutics
Novartis
Gritstone Oncology
IMAB-I-Mab Biopharma Co., Ltd.
Janssen Biotech
Autolus Therapeutics
Allogene Therapeutics
Bristol-Myers Squibb
Merck
Eli-Lilly
Takeda
GlaxoSmithKline
Arcus Biosciences
Roche
AstraZeneca
Sanofi
In Chapter 5 and Chapter 7.3, based on types, the Immuno-oncology Therapy market from 2017 to 2027 is primarily split into:
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
In Chapter 6 and Chapter 7.4, based on applications, the Immuno-oncology Therapy market from 2017 to 2027 covers:
Hospitals
Ambulatory Surgical Center
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Immuno-oncology Therapy market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Immuno-oncology Therapy Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 IMMUNO-ONCOLOGY THERAPY MARKET OVERVIEW
1.1 Product Overview and Scope of Immuno-oncology Therapy Market
1.2 Immuno-oncology Therapy Market Segment by Type
1.2.1 Global Immuno-oncology Therapy Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Immuno-oncology Therapy Market Segment by Application
1.3.1 Immuno-oncology Therapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Immuno-oncology Therapy Market, Region Wise (2017-2027)
1.4.1 Global Immuno-oncology Therapy Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Immuno-oncology Therapy Market Status and Prospect (2017-2027)
1.4.3 Europe Immuno-oncology Therapy Market Status and Prospect (2017-2027)
1.4.4 China Immuno-oncology Therapy Market Status and Prospect (2017-2027)
1.4.5 Japan Immuno-oncology Therapy Market Status and Prospect (2017-2027)
1.4.6 India Immuno-oncology Therapy Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Immuno-oncology Therapy Market Status and Prospect (2017-2027)
1.4.8 Latin America Immuno-oncology Therapy Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Immuno-oncology Therapy Market Status and Prospect (2017-2027)
1.5 Global Market Size of Immuno-oncology Therapy (2017-2027)
1.5.1 Global Immuno-oncology Therapy Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Immuno-oncology Therapy Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Immuno-oncology Therapy Market
2 INDUSTRY OUTLOOK
2.1 Immuno-oncology Therapy Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Immuno-oncology Therapy Market Drivers Analysis
2.4 Immuno-oncology Therapy Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Immuno-oncology Therapy Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Immuno-oncology Therapy Industry Development
3 GLOBAL IMMUNO-ONCOLOGY THERAPY MARKET LANDSCAPE BY PLAYER
3.1 Global Immuno-oncology Therapy Sales Volume and Share by Player (2017-2022)
3.2 Global Immuno-oncology Therapy Revenue and Market Share by Player (2017-2022)
3.3 Global Immuno-oncology Therapy Average Price by Player (2017-2022)
3.4 Global Immuno-oncology Therapy Gross Margin by Player (2017-2022)
3.5 Immuno-oncology Therapy Market Competitive Situation and Trends
3.5.1 Immuno-oncology Therapy Market Concentration Rate
3.5.2 Immuno-oncology Therapy Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL IMMUNO-ONCOLOGY THERAPY SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Immuno-oncology Therapy Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Immuno-oncology Therapy Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Immuno-oncology Therapy Market Under COVID-19
4.5 Europe Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Immuno-oncology Therapy Market Under COVID-19
4.6 China Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Immuno-oncology Therapy Market Under COVID-19
4.7 Japan Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Immuno-oncology Therapy Market Under COVID-19
4.8 India Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Immuno-oncology Therapy Market Under COVID-19
4.9 Southeast Asia Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Immuno-oncology Therapy Market Under COVID-19
4.10 Latin America Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Immuno-oncology Therapy Market Under COVID-19
4.11 Middle East and Africa Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Immuno-oncology Therapy Market Under COVID-19
5 GLOBAL IMMUNO-ONCOLOGY THERAPY SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Immuno-oncology Therapy Sales Volume and Market Share by Type (2017-2022)
5.2 Global Immuno-oncology Therapy Revenue and Market Share by Type (2017-2022)
5.3 Global Immuno-oncology Therapy Price by Type (2017-2022)
5.4 Global Immuno-oncology Therapy Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Immuno-oncology Therapy Sales Volume, Revenue and Growth Rate of Monoclonal Antibodies (2017-2022)
5.4.2 Global Immuno-oncology Therapy Sales Volume, Revenue and Growth Rate of Immune Checkpoint Inhibitors (2017-2022)
5.4.3 Global Immuno-oncology Therapy Sales Volume, Revenue and Growth Rate of Immune System Modulators (2017-2022)
5.4.4 Global Immuno-oncology Therapy Sales Volume, Revenue and Growth Rate of Cancer Vaccines (2017-2022)
6 GLOBAL IMMUNO-ONCOLOGY THERAPY MARKET ANALYSIS BY APPLICATION
6.1 Global Immuno-oncology Therapy Consumption and Market Share by Application (2017-2022)
6.2 Global Immuno-oncology Therapy Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Immuno-oncology Therapy Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Immuno-oncology Therapy Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Immuno-oncology Therapy Consumption and Growth Rate of Ambulatory Surgical Center (2017-2022)
6.3.3 Global Immuno-oncology Therapy Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL IMMUNO-ONCOLOGY THERAPY MARKET FORECAST (2022-2027)
7.1 Global Immuno-oncology Therapy Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Immuno-oncology Therapy Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Immuno-oncology Therapy Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Immuno-oncology Therapy Price and Trend Forecast (2022-2027)
7.2 Global Immuno-oncology Therapy Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Immuno-oncology Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Immuno-oncology Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Immuno-oncology Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Immuno-oncology Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Immuno-oncology Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Immuno-oncology Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Immuno-oncology Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Immuno-oncology Therapy Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Immuno-oncology Therapy Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Immuno-oncology Therapy Revenue and Growth Rate of Monoclonal Antibodies (2022-2027)
7.3.2 Global Immuno-oncology Therapy Revenue and Growth Rate of Immune Checkpoint Inhibitors (2022-2027)
7.3.3 Global Immuno-oncology Therapy Revenue and Growth Rate of Immune System Modulators (2022-2027)
7.3.4 Global Immuno-oncology Therapy Revenue and Growth Rate of Cancer Vaccines (2022-2027)
7.4 Global Immuno-oncology Therapy Consumption Forecast by Application (2022-2027)
7.4.1 Global Immuno-oncology Therapy Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.2 Global Immuno-oncology Therapy Consumption Value and Growth Rate of Ambulatory Surgical Center(2022-2027)
7.4.3 Global Immuno-oncology Therapy Consumption Value and Growth Rate of Others(2022-2027)
7.5 Immuno-oncology Therapy Market Forecast Under COVID-19
8 IMMUNO-ONCOLOGY THERAPY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Immuno-oncology Therapy Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Immuno-oncology Therapy Analysis
8.6 Major Downstream Buyers of Immuno-oncology Therapy Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Immuno-oncology Therapy Industry
9 PLAYERS PROFILES
9.1 Spectrum Pharmaceuticals
9.1.1 Spectrum Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.1.3 Spectrum Pharmaceuticals Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Amgen
9.2.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.2.3 Amgen Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 BioNTech SE
9.3.1 BioNTech SE Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.3.3 BioNTech SE Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Pfizer
9.4.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.4.3 Pfizer Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Rubius Therapeutics
9.5.1 Rubius Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.5.3 Rubius Therapeutics Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Novartis
9.6.1 Novartis Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.6.3 Novartis Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Gritstone Oncology
9.7.1 Gritstone Oncology Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.7.3 Gritstone Oncology Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 IMAB-I-Mab Biopharma Co., Ltd.
9.8.1 IMAB-I-Mab Biopharma Co., Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.8.3 IMAB-I-Mab Biopharma Co., Ltd. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Janssen Biotech
9.9.1 Janssen Biotech Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.9.3 Janssen Biotech Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Autolus Therapeutics
9.10.1 Autolus Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.10.3 Autolus Therapeutics Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Allogene Therapeutics
9.11.1 Allogene Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.11.3 Allogene Therapeutics Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Bristol-Myers Squibb
9.12.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.12.3 Bristol-Myers Squibb Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Merck
9.13.1 Merck Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.13.3 Merck Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Eli-Lilly
9.14.1 Eli-Lilly Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.14.3 Eli-Lilly Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Takeda
9.15.1 Takeda Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.15.3 Takeda Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 GlaxoSmithKline
9.16.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.16.3 GlaxoSmithKline Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Arcus Biosciences
9.17.1 Arcus Biosciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.17.3 Arcus Biosciences Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 Roche
9.18.1 Roche Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.18.3 Roche Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 AstraZeneca
9.19.1 AstraZeneca Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.19.3 AstraZeneca Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
9.20 Sanofi
9.20.1 Sanofi Basic Information, Manufacturing Base, Sales Region and Competitors
9.20.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.20.3 Sanofi Market Performance (2017-2022)
9.20.4 Recent Development
9.20.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Immuno-oncology Therapy Market
1.2 Immuno-oncology Therapy Market Segment by Type
1.2.1 Global Immuno-oncology Therapy Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Immuno-oncology Therapy Market Segment by Application
1.3.1 Immuno-oncology Therapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Immuno-oncology Therapy Market, Region Wise (2017-2027)
1.4.1 Global Immuno-oncology Therapy Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Immuno-oncology Therapy Market Status and Prospect (2017-2027)
1.4.3 Europe Immuno-oncology Therapy Market Status and Prospect (2017-2027)
1.4.4 China Immuno-oncology Therapy Market Status and Prospect (2017-2027)
1.4.5 Japan Immuno-oncology Therapy Market Status and Prospect (2017-2027)
1.4.6 India Immuno-oncology Therapy Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Immuno-oncology Therapy Market Status and Prospect (2017-2027)
1.4.8 Latin America Immuno-oncology Therapy Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Immuno-oncology Therapy Market Status and Prospect (2017-2027)
1.5 Global Market Size of Immuno-oncology Therapy (2017-2027)
1.5.1 Global Immuno-oncology Therapy Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Immuno-oncology Therapy Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Immuno-oncology Therapy Market
2 INDUSTRY OUTLOOK
2.1 Immuno-oncology Therapy Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Immuno-oncology Therapy Market Drivers Analysis
2.4 Immuno-oncology Therapy Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Immuno-oncology Therapy Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Immuno-oncology Therapy Industry Development
3 GLOBAL IMMUNO-ONCOLOGY THERAPY MARKET LANDSCAPE BY PLAYER
3.1 Global Immuno-oncology Therapy Sales Volume and Share by Player (2017-2022)
3.2 Global Immuno-oncology Therapy Revenue and Market Share by Player (2017-2022)
3.3 Global Immuno-oncology Therapy Average Price by Player (2017-2022)
3.4 Global Immuno-oncology Therapy Gross Margin by Player (2017-2022)
3.5 Immuno-oncology Therapy Market Competitive Situation and Trends
3.5.1 Immuno-oncology Therapy Market Concentration Rate
3.5.2 Immuno-oncology Therapy Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL IMMUNO-ONCOLOGY THERAPY SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Immuno-oncology Therapy Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Immuno-oncology Therapy Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Immuno-oncology Therapy Market Under COVID-19
4.5 Europe Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Immuno-oncology Therapy Market Under COVID-19
4.6 China Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Immuno-oncology Therapy Market Under COVID-19
4.7 Japan Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Immuno-oncology Therapy Market Under COVID-19
4.8 India Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Immuno-oncology Therapy Market Under COVID-19
4.9 Southeast Asia Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Immuno-oncology Therapy Market Under COVID-19
4.10 Latin America Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Immuno-oncology Therapy Market Under COVID-19
4.11 Middle East and Africa Immuno-oncology Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Immuno-oncology Therapy Market Under COVID-19
5 GLOBAL IMMUNO-ONCOLOGY THERAPY SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Immuno-oncology Therapy Sales Volume and Market Share by Type (2017-2022)
5.2 Global Immuno-oncology Therapy Revenue and Market Share by Type (2017-2022)
5.3 Global Immuno-oncology Therapy Price by Type (2017-2022)
5.4 Global Immuno-oncology Therapy Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Immuno-oncology Therapy Sales Volume, Revenue and Growth Rate of Monoclonal Antibodies (2017-2022)
5.4.2 Global Immuno-oncology Therapy Sales Volume, Revenue and Growth Rate of Immune Checkpoint Inhibitors (2017-2022)
5.4.3 Global Immuno-oncology Therapy Sales Volume, Revenue and Growth Rate of Immune System Modulators (2017-2022)
5.4.4 Global Immuno-oncology Therapy Sales Volume, Revenue and Growth Rate of Cancer Vaccines (2017-2022)
6 GLOBAL IMMUNO-ONCOLOGY THERAPY MARKET ANALYSIS BY APPLICATION
6.1 Global Immuno-oncology Therapy Consumption and Market Share by Application (2017-2022)
6.2 Global Immuno-oncology Therapy Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Immuno-oncology Therapy Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Immuno-oncology Therapy Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Immuno-oncology Therapy Consumption and Growth Rate of Ambulatory Surgical Center (2017-2022)
6.3.3 Global Immuno-oncology Therapy Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL IMMUNO-ONCOLOGY THERAPY MARKET FORECAST (2022-2027)
7.1 Global Immuno-oncology Therapy Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Immuno-oncology Therapy Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Immuno-oncology Therapy Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Immuno-oncology Therapy Price and Trend Forecast (2022-2027)
7.2 Global Immuno-oncology Therapy Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Immuno-oncology Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Immuno-oncology Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Immuno-oncology Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Immuno-oncology Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Immuno-oncology Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Immuno-oncology Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Immuno-oncology Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Immuno-oncology Therapy Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Immuno-oncology Therapy Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Immuno-oncology Therapy Revenue and Growth Rate of Monoclonal Antibodies (2022-2027)
7.3.2 Global Immuno-oncology Therapy Revenue and Growth Rate of Immune Checkpoint Inhibitors (2022-2027)
7.3.3 Global Immuno-oncology Therapy Revenue and Growth Rate of Immune System Modulators (2022-2027)
7.3.4 Global Immuno-oncology Therapy Revenue and Growth Rate of Cancer Vaccines (2022-2027)
7.4 Global Immuno-oncology Therapy Consumption Forecast by Application (2022-2027)
7.4.1 Global Immuno-oncology Therapy Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.2 Global Immuno-oncology Therapy Consumption Value and Growth Rate of Ambulatory Surgical Center(2022-2027)
7.4.3 Global Immuno-oncology Therapy Consumption Value and Growth Rate of Others(2022-2027)
7.5 Immuno-oncology Therapy Market Forecast Under COVID-19
8 IMMUNO-ONCOLOGY THERAPY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Immuno-oncology Therapy Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Immuno-oncology Therapy Analysis
8.6 Major Downstream Buyers of Immuno-oncology Therapy Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Immuno-oncology Therapy Industry
9 PLAYERS PROFILES
9.1 Spectrum Pharmaceuticals
9.1.1 Spectrum Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.1.3 Spectrum Pharmaceuticals Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Amgen
9.2.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.2.3 Amgen Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 BioNTech SE
9.3.1 BioNTech SE Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.3.3 BioNTech SE Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Pfizer
9.4.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.4.3 Pfizer Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Rubius Therapeutics
9.5.1 Rubius Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.5.3 Rubius Therapeutics Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Novartis
9.6.1 Novartis Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.6.3 Novartis Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Gritstone Oncology
9.7.1 Gritstone Oncology Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.7.3 Gritstone Oncology Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 IMAB-I-Mab Biopharma Co., Ltd.
9.8.1 IMAB-I-Mab Biopharma Co., Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.8.3 IMAB-I-Mab Biopharma Co., Ltd. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Janssen Biotech
9.9.1 Janssen Biotech Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.9.3 Janssen Biotech Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Autolus Therapeutics
9.10.1 Autolus Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.10.3 Autolus Therapeutics Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Allogene Therapeutics
9.11.1 Allogene Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.11.3 Allogene Therapeutics Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Bristol-Myers Squibb
9.12.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.12.3 Bristol-Myers Squibb Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Merck
9.13.1 Merck Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.13.3 Merck Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Eli-Lilly
9.14.1 Eli-Lilly Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.14.3 Eli-Lilly Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Takeda
9.15.1 Takeda Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.15.3 Takeda Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 GlaxoSmithKline
9.16.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.16.3 GlaxoSmithKline Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Arcus Biosciences
9.17.1 Arcus Biosciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.17.3 Arcus Biosciences Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 Roche
9.18.1 Roche Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.18.3 Roche Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 AstraZeneca
9.19.1 AstraZeneca Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.19.3 AstraZeneca Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
9.20 Sanofi
9.20.1 Sanofi Basic Information, Manufacturing Base, Sales Region and Competitors
9.20.2 Immuno-oncology Therapy Product Profiles, Application and Specification
9.20.3 Sanofi Market Performance (2017-2022)
9.20.4 Recent Development
9.20.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Immuno-oncology Therapy Product Picture
Table Global Immuno-oncology Therapy Market Sales Volume and CAGR (%) Comparison by Type
Table Immuno-oncology Therapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Immuno-oncology Therapy Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Immuno-oncology Therapy Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Immuno-oncology Therapy Industry Development
Table Global Immuno-oncology Therapy Sales Volume by Player (2017-2022)
Table Global Immuno-oncology Therapy Sales Volume Share by Player (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume Share by Player in 2021
Table Immuno-oncology Therapy Revenue (Million USD) by Player (2017-2022)
Table Immuno-oncology Therapy Revenue Market Share by Player (2017-2022)
Table Immuno-oncology Therapy Price by Player (2017-2022)
Table Immuno-oncology Therapy Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Immuno-oncology Therapy Sales Volume, Region Wise (2017-2022)
Table Global Immuno-oncology Therapy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume Market Share, Region Wise in 2021
Table Global Immuno-oncology Therapy Revenue (Million USD), Region Wise (2017-2022)
Table Global Immuno-oncology Therapy Revenue Market Share, Region Wise (2017-2022)
Figure Global Immuno-oncology Therapy Revenue Market Share, Region Wise (2017-2022)
Figure Global Immuno-oncology Therapy Revenue Market Share, Region Wise in 2021
Table Global Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Immuno-oncology Therapy Sales Volume by Type (2017-2022)
Table Global Immuno-oncology Therapy Sales Volume Market Share by Type (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume Market Share by Type in 2021
Table Global Immuno-oncology Therapy Revenue (Million USD) by Type (2017-2022)
Table Global Immuno-oncology Therapy Revenue Market Share by Type (2017-2022)
Figure Global Immuno-oncology Therapy Revenue Market Share by Type in 2021
Table Immuno-oncology Therapy Price by Type (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume and Growth Rate of Monoclonal Antibodies (2017-2022)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume and Growth Rate of Immune Checkpoint Inhibitors (2017-2022)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Immune Checkpoint Inhibitors (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume and Growth Rate of Immune System Modulators (2017-2022)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Immune System Modulators (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume and Growth Rate of Cancer Vaccines (2017-2022)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Cancer Vaccines (2017-2022)
Table Global Immuno-oncology Therapy Consumption by Application (2017-2022)
Table Global Immuno-oncology Therapy Consumption Market Share by Application (2017-2022)
Table Global Immuno-oncology Therapy Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Immuno-oncology Therapy Consumption Revenue Market Share by Application (2017-2022)
Table Global Immuno-oncology Therapy Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Immuno-oncology Therapy Consumption and Growth Rate of Ambulatory Surgical Center (2017-2022)
Table Global Immuno-oncology Therapy Consumption and Growth Rate of Others (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Immuno-oncology Therapy Price and Trend Forecast (2022-2027)
Figure USA Immuno-oncology Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Immuno-oncology Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Immuno-oncology Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Immuno-oncology Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Immuno-oncology Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Immuno-oncology Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Immuno-oncology Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Immuno-oncology Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Immuno-oncology Therapy Market Sales Volume Forecast, by Type
Table Global Immuno-oncology Therapy Sales Volume Market Share Forecast, by Type
Table Global Immuno-oncology Therapy Market Revenue (Million USD) Forecast, by Type
Table Global Immuno-oncology Therapy Revenue Market Share Forecast, by Type
Table Global Immuno-oncology Therapy Price Forecast, by Type
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2022-2027)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2022-2027)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Immune Checkpoint Inhibitors (2022-2027)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Immune Checkpoint Inhibitors (2022-2027)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Immune System Modulators (2022-2027)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Immune System Modulators (2022-2027)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Cancer Vaccines (2022-2027)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Cancer Vaccines (2022-2027)
Table Global Immuno-oncology Therapy Market Consumption Forecast, by Application
Table Global Immuno-oncology Therapy Consumption Market Share Forecast, by Application
Table Global Immuno-oncology Therapy Market Revenue (Million USD) Forecast, by Application
Table Global Immuno-oncology Therapy Revenue Market Share Forecast, by Application
Figure Global Immuno-oncology Therapy Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Immuno-oncology Therapy Consumption Value (Million USD) and Growth Rate of Ambulatory Surgical Center (2022-2027)
Figure Global Immuno-oncology Therapy Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Immuno-oncology Therapy Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Spectrum Pharmaceuticals Profile
Table Spectrum Pharmaceuticals Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Spectrum Pharmaceuticals Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Spectrum Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table BioNTech SE Profile
Table BioNTech SE Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure BioNTech SE Immuno-oncology Therapy Sales Volume and Growth Rate
Figure BioNTech SE Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Rubius Therapeutics Profile
Table Rubius Therapeutics Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Rubius Therapeutics Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Rubius Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Novartis Profile
Table Novartis Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Novartis Revenue (Million USD) Market Share 2017-2022
Table Gritstone Oncology Profile
Table Gritstone Oncology Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Gritstone Oncology Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Gritstone Oncology Revenue (Million USD) Market Share 2017-2022
Table IMAB-I-Mab Biopharma Co., Ltd. Profile
Table IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Sales Volume and Growth Rate
Figure IMAB-I-Mab Biopharma Co., Ltd. Revenue (Million USD) Market Share 2017-2022
Table Janssen Biotech Profile
Table Janssen Biotech Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Janssen Biotech Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Janssen Biotech Revenue (Million USD) Market Share 2017-2022
Table Autolus Therapeutics Profile
Table Autolus Therapeutics Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Autolus Therapeutics Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Autolus Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Allogene Therapeutics Profile
Table Allogene Therapeutics Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Allogene Therapeutics Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Allogene Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Revenue (Million USD) Market Share 2017-2022
Table Merck Profile
Table Merck Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Merck Revenue (Million USD) Market Share 2017-2022
Table Eli-Lilly Profile
Table Eli-Lilly Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eli-Lilly Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Eli-Lilly Revenue (Million USD) Market Share 2017-2022
Table Takeda Profile
Table Takeda Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Takeda Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Takeda Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline Profile
Table GlaxoSmithKline Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline Immuno-oncology Therapy Sales Volume and Growth Rate
Figure GlaxoSmithKline Revenue (Million USD) Market Share 2017-2022
Table Arcus Biosciences Profile
Table Arcus Biosciences Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Arcus Biosciences Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Arcus Biosciences Revenue (Million USD) Market Share 2017-2022
Table Roche Profile
Table Roche Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Roche Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Roche Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca Profile
Table AstraZeneca Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca Immuno-oncology Therapy Sales Volume and Growth Rate
Figure AstraZeneca Revenue (Million USD) Market Share 2017-2022
Table Sanofi Profile
Table Sanofi Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Sanofi Revenue (Million USD) Market Share 2017-2022
Figure Immuno-oncology Therapy Product Picture
Table Global Immuno-oncology Therapy Market Sales Volume and CAGR (%) Comparison by Type
Table Immuno-oncology Therapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Immuno-oncology Therapy Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Immuno-oncology Therapy Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Immuno-oncology Therapy Industry Development
Table Global Immuno-oncology Therapy Sales Volume by Player (2017-2022)
Table Global Immuno-oncology Therapy Sales Volume Share by Player (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume Share by Player in 2021
Table Immuno-oncology Therapy Revenue (Million USD) by Player (2017-2022)
Table Immuno-oncology Therapy Revenue Market Share by Player (2017-2022)
Table Immuno-oncology Therapy Price by Player (2017-2022)
Table Immuno-oncology Therapy Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Immuno-oncology Therapy Sales Volume, Region Wise (2017-2022)
Table Global Immuno-oncology Therapy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume Market Share, Region Wise in 2021
Table Global Immuno-oncology Therapy Revenue (Million USD), Region Wise (2017-2022)
Table Global Immuno-oncology Therapy Revenue Market Share, Region Wise (2017-2022)
Figure Global Immuno-oncology Therapy Revenue Market Share, Region Wise (2017-2022)
Figure Global Immuno-oncology Therapy Revenue Market Share, Region Wise in 2021
Table Global Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Immuno-oncology Therapy Sales Volume by Type (2017-2022)
Table Global Immuno-oncology Therapy Sales Volume Market Share by Type (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume Market Share by Type in 2021
Table Global Immuno-oncology Therapy Revenue (Million USD) by Type (2017-2022)
Table Global Immuno-oncology Therapy Revenue Market Share by Type (2017-2022)
Figure Global Immuno-oncology Therapy Revenue Market Share by Type in 2021
Table Immuno-oncology Therapy Price by Type (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume and Growth Rate of Monoclonal Antibodies (2017-2022)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume and Growth Rate of Immune Checkpoint Inhibitors (2017-2022)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Immune Checkpoint Inhibitors (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume and Growth Rate of Immune System Modulators (2017-2022)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Immune System Modulators (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume and Growth Rate of Cancer Vaccines (2017-2022)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Cancer Vaccines (2017-2022)
Table Global Immuno-oncology Therapy Consumption by Application (2017-2022)
Table Global Immuno-oncology Therapy Consumption Market Share by Application (2017-2022)
Table Global Immuno-oncology Therapy Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Immuno-oncology Therapy Consumption Revenue Market Share by Application (2017-2022)
Table Global Immuno-oncology Therapy Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Immuno-oncology Therapy Consumption and Growth Rate of Ambulatory Surgical Center (2017-2022)
Table Global Immuno-oncology Therapy Consumption and Growth Rate of Others (2017-2022)
Figure Global Immuno-oncology Therapy Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Immuno-oncology Therapy Price and Trend Forecast (2022-2027)
Figure USA Immuno-oncology Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Immuno-oncology Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Immuno-oncology Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Immuno-oncology Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Immuno-oncology Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Immuno-oncology Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Immuno-oncology Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Immuno-oncology Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Immuno-oncology Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Immuno-oncology Therapy Market Sales Volume Forecast, by Type
Table Global Immuno-oncology Therapy Sales Volume Market Share Forecast, by Type
Table Global Immuno-oncology Therapy Market Revenue (Million USD) Forecast, by Type
Table Global Immuno-oncology Therapy Revenue Market Share Forecast, by Type
Table Global Immuno-oncology Therapy Price Forecast, by Type
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2022-2027)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2022-2027)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Immune Checkpoint Inhibitors (2022-2027)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Immune Checkpoint Inhibitors (2022-2027)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Immune System Modulators (2022-2027)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Immune System Modulators (2022-2027)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Cancer Vaccines (2022-2027)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate of Cancer Vaccines (2022-2027)
Table Global Immuno-oncology Therapy Market Consumption Forecast, by Application
Table Global Immuno-oncology Therapy Consumption Market Share Forecast, by Application
Table Global Immuno-oncology Therapy Market Revenue (Million USD) Forecast, by Application
Table Global Immuno-oncology Therapy Revenue Market Share Forecast, by Application
Figure Global Immuno-oncology Therapy Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Immuno-oncology Therapy Consumption Value (Million USD) and Growth Rate of Ambulatory Surgical Center (2022-2027)
Figure Global Immuno-oncology Therapy Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Immuno-oncology Therapy Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Spectrum Pharmaceuticals Profile
Table Spectrum Pharmaceuticals Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Spectrum Pharmaceuticals Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Spectrum Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table BioNTech SE Profile
Table BioNTech SE Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure BioNTech SE Immuno-oncology Therapy Sales Volume and Growth Rate
Figure BioNTech SE Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Rubius Therapeutics Profile
Table Rubius Therapeutics Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Rubius Therapeutics Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Rubius Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Novartis Profile
Table Novartis Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Novartis Revenue (Million USD) Market Share 2017-2022
Table Gritstone Oncology Profile
Table Gritstone Oncology Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Gritstone Oncology Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Gritstone Oncology Revenue (Million USD) Market Share 2017-2022
Table IMAB-I-Mab Biopharma Co., Ltd. Profile
Table IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Sales Volume and Growth Rate
Figure IMAB-I-Mab Biopharma Co., Ltd. Revenue (Million USD) Market Share 2017-2022
Table Janssen Biotech Profile
Table Janssen Biotech Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Janssen Biotech Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Janssen Biotech Revenue (Million USD) Market Share 2017-2022
Table Autolus Therapeutics Profile
Table Autolus Therapeutics Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Autolus Therapeutics Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Autolus Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Allogene Therapeutics Profile
Table Allogene Therapeutics Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Allogene Therapeutics Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Allogene Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Revenue (Million USD) Market Share 2017-2022
Table Merck Profile
Table Merck Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Merck Revenue (Million USD) Market Share 2017-2022
Table Eli-Lilly Profile
Table Eli-Lilly Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eli-Lilly Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Eli-Lilly Revenue (Million USD) Market Share 2017-2022
Table Takeda Profile
Table Takeda Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Takeda Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Takeda Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline Profile
Table GlaxoSmithKline Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline Immuno-oncology Therapy Sales Volume and Growth Rate
Figure GlaxoSmithKline Revenue (Million USD) Market Share 2017-2022
Table Arcus Biosciences Profile
Table Arcus Biosciences Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Arcus Biosciences Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Arcus Biosciences Revenue (Million USD) Market Share 2017-2022
Table Roche Profile
Table Roche Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Roche Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Roche Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca Profile
Table AstraZeneca Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca Immuno-oncology Therapy Sales Volume and Growth Rate
Figure AstraZeneca Revenue (Million USD) Market Share 2017-2022
Table Sanofi Profile
Table Sanofi Immuno-oncology Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi Immuno-oncology Therapy Sales Volume and Growth Rate
Figure Sanofi Revenue (Million USD) Market Share 2017-2022
